ID: ALA596546

Max Phase: Preclinical

Molecular Formula: C14H10O2S

Molecular Weight: 242.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  [O-][s+]1cc(Oc2ccccc2)c2ccccc21

Standard InChI:  InChI=1S/C14H10O2S/c15-17-10-13(12-8-4-5-9-14(12)17)16-11-6-2-1-3-7-11/h1-10H

Standard InChI Key:  CZJLSJJLZCWZTM-UHFFFAOYSA-N

Associated Targets(non-human)

Intestinal alkaline phosphatase 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 242.30Molecular Weight (Monoisotopic): 242.0402AlogP: 4.36#Rotatable Bonds: 2
Polar Surface Area: 32.29Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.12CX LogD: 2.12
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.63Np Likeness Score: -0.26

References

1. Li L, Chang L, Pellet-Rostaing S, Liger F, Lemaire M, Buchet R, Wu Y..  (2009)  Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.,  17  (20): [PMID:19781951] [10.1016/j.bmc.2009.08.048]

Source